| Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype B Falini, C Mecucci, E Tiacci, M Alcalay, R Rosati, L Pasqualucci, ... New England Journal of Medicine 352 (3), 254-266, 2005 | 2360 | 2005 |
| BRAF mutations in hairy-cell leukemia E Tiacci, V Trifonov, G Schiavoni, A Holmes, W Kern, MP Martelli, ... New England Journal of Medicine 364 (24), 2305-2315, 2011 | 1246 | 2011 |
| Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin R Garzon, M Garofalo, MP Martelli, R Briesewitz, L Wang, ... Proceedings of the National Academy of Sciences 105 (10), 3945-3950, 2008 | 655 | 2008 |
| Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma—a feasibility study VL Reichardt, CY Okada, A Liso, CJ Benike, KE Stockerl-Goldstein, ... Blood, The Journal of the American Society of Hematology 93 (7), 2411-2419, 1999 | 537 | 1999 |
| Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML B Falini, N Bolli, J Shan, MP Martelli, A Liso, A Pucciarini, B Bigerna, ... Blood 107 (11), 4514-4523, 2006 | 375 | 2006 |
| Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? B Falini, MP Martelli, N Bolli, P Sportoletti, A Liso, E Tiacci, T Haferlach Blood, The Journal of the American Society of Hematology 117 (4), 1109-1120, 2011 | 312 | 2011 |
| Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications B Falini, N Bolli, A Liso, MP Martelli, R Mannucci, S Pileri, I Nicoletti Leukemia 23 (10), 1731-1743, 2009 | 308 | 2009 |
| Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype V Grossmann, E Tiacci, AB Holmes, A Kohlmann, MP Martelli, W Kern, ... Blood, The Journal of the American Society of Hematology 118 (23), 6153-6163, 2011 | 304 | 2011 |
| Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias B Falini, I Nicoletti, N Bolli, MP Martelli, A Liso, P Gorello, F Mandelli, ... haematologica 92 (4), 519-532, 2007 | 284 | 2007 |
| Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1) B Falini, E Tiacci, A Liso, K Basso, E Sabattini, R Pacini, R Foa, A Pulsoni, ... The Lancet 363 (9424), 1869-1871, 2004 | 278 | 2004 |
| Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors K Basso, A Liso, E Tiacci, R Benedetti, A Pulsoni, R Foa, F Di Raimondo, ... The Journal of experimental medicine 199 (1), 59-68, 2004 | 232 | 2004 |
| Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia B Falini, MP Martelli, N Bolli, R Bonasso, E Ghia, MT Pallotta, D Diverio, ... Blood 108 (6), 1999-2005, 2006 | 221 | 2006 |
| Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin H Quentmeier, MP Martelli, WG Dirks, N Bolli, A Liso, RAF MacLeod, ... Leukemia 19 (10), 1760-1767, 2005 | 216 | 2005 |
| Abnormal pattern of lymphocyte subpopulations in the endometrium of infertile women with chronic endometritis M Matteo, E Cicinelli, P Greco, F Massenzio, D Baldini, T Falagario, ... American journal of reproductive immunology 61 (5), 322-329, 2009 | 198 | 2009 |
| T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction S Colucci, G Brunetti, R Rizzi, A Zonno, G Mori, G Colaianni, D Del Prete, ... Blood 104 (12), 3722-3730, 2004 | 175 | 2004 |
| Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma A Liso, KE Stockerl-Goldstein, S Auffermann-Gretzinger, CJ Benike, ... Biology of Blood and Marrow Transplantation 6 (6), 621-627, 2000 | 174 | 2000 |
| Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas B Falini, D Lenze, R Hasserjian, S Coupland, D Jaehne, C Soupir, A Liso, ... Leukemia 21 (7), 1566-1570, 2007 | 167 | 2007 |
| Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML) B Falini, L Flenghi, M Fagioli, FL Coco, I Cordone, D Diverio, ... Blood, The Journal of the American Society of Hematology 90 (10), 4046-4053, 1997 | 164 | 1997 |
| FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experience D Pastore, G Specchia, P Carluccio, A Liso, A Mestice, R Rizzi, G Greco, ... Annals of hematology 82, 231-235, 2003 | 160 | 2003 |
| CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice MP Martelli, V Pettirossi, C Thiede, E Bonifacio, F Mezzasoma, D Cecchini, ... Blood, The Journal of the American Society of Hematology 116 (19), 3907-3922, 2010 | 140 | 2010 |
